SEC Filing Summary for Moore Duncan

Moore Duncan, a director at ASP Isotopes Inc., reported several transactions involving the company's common stock. On November 12, 2025, Duncan acquired 25,469 shares as part of an annual award of restricted stock for his role on the QLE Structuring and Strategic Transactions Committee. This was followed by another acquisition of 36,548 shares on December 18, 2025, also an annual restricted stock award. On April 16, 2026, Duncan sold 11,642 shares at a weighted average price of $5.205 per share. This sale was executed under a Rule 10b5-1 trading plan and included shares to cover tax liabilities from a previous restricted stock award vesting. The sale occurred at prices ranging from $5.055 to $5.52 per share. Following these transactions, Duncan holds 1,044,928 shares of common stock.